Search

Your search keyword '"Balercia, G"' showing total 24 results
Start Over Author "Balercia, G" Publisher springer science and business media llc
24 results on '"Balercia, G"'

2. The use of follicle stimulating hormone (FSH) for the treatment of the infertile man: position statement from the Italian Society of Andrology and Sexual Medicine (SIAMS)

Author

Barbonetti, A., primary, Calogero, A. E., additional, Balercia, G., additional, Garolla, A., additional, Krausz, C., additional, La Vignera, S., additional, Lombardo, F., additional, Jannini, E. A., additional, Maggi, M., additional, Lenzi, A., additional, Foresta, C., additional, and Ferlin, A., additional

Published
2018
Full Text
View/download PDF

5. Vitamin D and thyroid disease: to D or not to D?

Author

Muscogiuri, G, primary, Tirabassi, G, additional, Bizzaro, G, additional, Orio, F, additional, Paschou, S A, additional, Vryonidou, A, additional, Balercia, G, additional, Shoenfeld, Y, additional, and Colao, A, additional

Published
2014
Full Text
View/download PDF

7. Erratum to: GLP-1: benefits beyond pancreas

Author

Muscogiuri, G., primary, Cignarelli, A., additional, Giorgino, F., additional, Prodam, F., additional, Santi, D., additional, Tirabassi, G., additional, Balercia, G., additional, Modica, R., additional, Faggiano, A., additional, and Colao, A., additional

Published
2014
Full Text
View/download PDF

9. GLP-1: benefits beyond pancreas

Author

Muscogiuri, G., primary, Cignarelli, A., additional, Giorgino, F., additional, Prodram, F., additional, Santi, D., additional, Tirabassi, G., additional, Balercia, G., additional, Modica, R., additional, Faggiano, A., additional, and Colao, A., additional

Published
2014
Full Text
View/download PDF

13. Epidemiology; diagnosis, and treatment of male hypogonadotropic hypogonadism

Author

Lenzi, A., primary, Balercia, G., additional, Bellastella, A., additional, Colao, A., additional, Fabbri, A., additional, Foresta, C., additional, Galdiero, M., additional, Gandini, L., additional, Krausz, C., additional, Lombardi, G., additional, Lombardo, F., additional, Maggi, M., additional, Radicioni, A., additional, Selice, R., additional, Sinisi, A. A., additional, and Forti, G., additional

Published
2009
Full Text
View/download PDF

14. Coenzyme Q10 and male infertility

Author

Balercia, G., primary, Mancini, A., additional, Paggi, F., additional, Tiano, L., additional, Pontecorvi, A., additional, Boscaro, M., additional, Lenzi, A., additional, and Littarru, G. P., additional

Published
2009
Full Text
View/download PDF

21. Expression of progesterone receptors in solid-cystic tumour of the pancreas

Author

Zamboni, G., primary, Bonetti, F., additional, Scarpa, A., additional, Pelosi, G., additional, Doglioni, C., additional, Iannucci, A., additional, Castelli, P., additional, Balercia, G., additional, Aldovini, D., additional, Bellomi, A., additional, Iacono, C., additional, Serio, G., additional, and Mariuzzi, G. M., additional

Published
1993
Full Text
View/download PDF

24. GLP-1: benefits beyond pancreas

Author

G, Muscogiuri, A, Cignarelli, F, Giorgino, F, Prodam, F, Prodram, D, Santi, G, Tirabassi, G, Balercia, R, Modica, A, Faggiano, A, Colao, Muscogiuri, Giovanna, Cignarelli, A, Giorgino, F, Prodram, F, Santi, D, Tirabassi, G, Balercia, G, Modica, R, Faggiano, Antongiulio, and Colao, Annamaria

Subjects
cardiovascular risk, endocrine system, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Central nervous system, Type 2 diabetes, Biology, Bone remodeling, body weight, Endocrinology, Glucagon-Like Peptide 1, Risk Factors, Internal medicine, Diabetes mellitus, Bone cell, medicine, Animals, Humans, Obesity, Receptor, Pancreas, Kidney, nervous system, digestive, oral, and skin physiology, medicine.disease, medicine.anatomical_structure, GLP1, pancreas, Diabetes Mellitus, Type 2, Cardiovascular Diseases, hormones, hormone substitutes, and hormone antagonists
Abstract

Introduction: Glucagon-like peptide 1 (GLP-1) is an intestinal hormone secreted after the ingestion of various nutrients. The main role of GLP-1 is to stimulate insulin secretion in a glucose-dependent manner. However, the expression of GLP-1 receptor was found to be expressed in a variety of tissues beyond pancreas such as lung, stomach, intestine, kidney, heart and brain. Beyond pancreas, a beneficial effect of GLP-1 on body weight reduction has been shown, suggesting its role for the treatment of obesity. In addition, GLP-1 has been demonstrated to reduce cardiovascular risk factors and to have a direct cardioprotective effect, fostering heart recovery after ischemic injury. Further, data from both experimental animal models and human studies have shown beneficial effect of GLP-1 on bone metabolism, either directly or indirectly on bone cells. Materials and methods: We review here the recent findings of the extra-pancreatic effects of GLP-1 focusing on both basic and clinical studies, thus opening future perspectives to the use of GLP-1 analogs for the treatment of disease beyond type 2 diabetes. Conclusion: Finally, the GLP-1 has been demonstrated to have a beneficial effect on both vascular, degenerative diseases of central nervous system and psoriasis.

Published
2014

Catalog

Books, media, physical & digital resources
See catalog results